Multidimensional Regulatory Networks of Immune Resistance in Intrahepatic Cholangiocarcinoma: Synergistic Mechanisms of Tumor Microenvironment, Immune Cells, and Microbiota, and Novel Therapeutic Strategies
Gastrointestinal Disorders · 29.06.2026 · 8 (3) · 32
DOI: 10.3390/gidisord8030032 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gastrointestinal Disorders, online erschienen am 29.06.2026. Verfasst von Lingyu Kong und 1 weiteren Autor:innen. Die Arbeit nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Health Science and Technology Capacity Building Project of Health Commission of Jilin Province.
Abstract (Originalsprache)
Cholangiocarcinoma (CCA) is a highly malignant tumor originating from the epithelium of the bile ducts. It has an insidious onset, is difficult to diagnose in its early stages, has a low rate of curative resection, and carries an extremely poor prognosis. Among these, intrahepatic cholangiocarcinoma (iCCA), as the most representative subtype, is a classic “immunologically cold tumor.” The response rate to single-agent immunotherapy is only 5–10%, and the mechanisms of immune resistance are complex and not yet fully elucidated. The tumor microenvironment, serving as the core site of immune resistance, forms a highly immunosuppressive network composed of cancer-associated fibroblasts, hypoxia, metabolic reprogramming, and epigenetic abnormalities; a population of immunosuppressive cells centered on tumor-associated macrophages further amplifies tolerance signals; and the gut–biliary microbiome exerts systemic immune regulation via the gut–liver axis. Based on mutant mouse models generated via tail vein injection and in-depth studies of mutations in key signaling pathways, our understanding of the mechanisms underlying iCCA’s immune resistance is deepening at both the molecular and systems levels. This article reviews the local and systemic regulatory mechanisms of immune resistance in primary iCCA, summarizes the research value of experimental and preclinical models, and reviews novel strategies such as tumor microenvironment remodeling, activation of immune cell networks, microbiome interventions, and multidimensional combination therapies. It analyzes current research bottlenecks and clinical challenges and outlines the future direction of precision immunotherapy, aiming to provide a theoretical basis and new insights for overcoming iCCA immunotherapy resistance and advancing clinical translation.
Förderung
- National Natural Science Foundation of China
- Health Science and Technology Capacity Building Project of Health Commission of Jilin Province
Zitieren
APA
Kong, L., & Piao, H. (2026). Multidimensional Regulatory Networks of Immune Resistance in Intrahepatic Cholangiocarcinoma: Synergistic Mechanisms of Tumor Microenvironment, Immune Cells, and Microbiota, and Novel Therapeutic Strategies. Gastrointestinal Disorders, 8(3), 32. https://doi.org/10.3390/gidisord8030032
Vancouver
Kong L, Piao H. Multidimensional Regulatory Networks of Immune Resistance in Intrahepatic Cholangiocarcinoma: Synergistic Mechanisms of Tumor Microenvironment, Immune Cells, and Microbiota, and Novel Therapeutic Strategies. Gastrointestinal Disorders. 2026;8(3):32. doi:10.3390/gidisord8030032
BibTeX
@article{Kong2026,
author = {Kong, Lingyu and Piao, Hongxin},
title = {Multidimensional Regulatory Networks of Immune Resistance in Intrahepatic Cholangiocarcinoma: Synergistic Mechanisms of Tumor Microenvironment, Immune Cells, and Microbiota, and Novel Therapeutic Strategies},
journal = {Gastrointestinal Disorders},
year = {2026},
volume = {8},
number = {3},
pages = {32},
doi = {10.3390/gidisord8030032}
}
EUVIMED